Salwa Almefareh: Bringing Life-Changing Haemophilia Care to Patients Worldwide
Salwa Almefareh, Regulatory Affairs Specialist at Roche Middle East, Mohamed Naser Al-Hajery and Sons Ltd., shared a post on LinkedIn:
“True innovation in haemophilia A extends beyond scientific discovery, it is realized when innovation reaches the patients who need it most.
At Roche, we believe meaningful progress is driven by strong partnerships and a shared commitment to improving global health.
Our long-term support of the World Federation of Hemophilia WFH Humanitarian Aid Program reflects this commitment, helping expand access to care for people living with inherited bleeding disorders in low- and middle-income countries.
By working together across the healthcare ecosystem, we can help reduce disparities in care, strengthen health systems, and create a future where more people with haemophilia have the opportunity to receive timely, life-changing treatment.
Learn how collaboration continues to shape the future of haemophilia care.”
Stay updated with Hemostasis Today.
-
Aug 26, 2026, 03:46Hugo Ribeiro: Which NSAIDs Are Safest for Older Adults?
-
Aug 25, 2026, 19:45Cara T. Hoepner: Omega-3 is Not an Exposure
-
Aug 25, 2026, 19:42Mark Skinner Honored With the Lifetime Achievement Award – National Bleeding Disorders Foundation
-
Aug 25, 2026, 19:41Katrina Snow: Honoured to Share NYG’s Ongoing QI Work Focused on Transfusion Safety in SCD
-
Aug 25, 2026, 19:39José María López Alemany: Madrid Makes an Urgent Appeal for Blood Donation as Reserves Fall to 38%
-
Aug 25, 2026, 19:36Carlos Mirel Peñate: How Are We Actually Managing AF in ATTR-CM?
-
Aug 25, 2026, 19:35Kelly Anderson: Anticoagulation and Cognitive Health in Older Adults With AF and Alzheimer’s Disease
-
Aug 25, 2026, 19:34Uriel Suárez: Managing Anticoagulation in Patients With Brain Metastases
-
Aug 25, 2026, 19:33Ali Moradi: Excited to Present Two Abstracts at AHA 2026